Fosun Pharmaceutical announced that as of the date of this announcement, the special fund has completed industrial and commercial registration and has received a total of RMB 30 million in capital contribution from all partners, and is pending filing with the China Securities Investment Fund Association. On March 24, 2026, the relevant parties signed a supplementary agreement to the framework agreement, agreeing to adjust the latest signing date of the transfer agreement to September 30, 2026.
復星医薬：売却資産の計画進展 専門基金の実払出資額は3000万円
Fosun Pharmaceutical announced that as of the date of this announcement, the special fund has completed industrial and commercial registration and has received a total of RMB 30 million in capital contribution from all partners, and is pending filing with the China Securities Investment Fund Association. On March 24, 2026, the relevant parties signed a supplementary agreement to the framework agreement, agreeing to adjust the latest signing date of the transfer agreement to September 30, 2026.